Beclomethasone dipropionate aerosol in the treatment of children with severe perennial rhinitis.
Twenty-two children suffering from severe perennial rhinitis were treated with intranasal beclomethasone dipropionate (300 microgram/day) and an identical placebo aerosol in a double-blind cross-over trial. The results confirmed the value of beclomethasone dipropionate in improving nasal symptoms and signs due to perennial rhinitis, and allergic eye symptoms caused by associated conjunctivitis.
D000281:Administration, Intranasal; D000293:Adolescent; D000336:Aerosols; D001507:Beclomethasone / Q000008:administration & dosage*; D002648:Child; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D010919:Placebos; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*
D000336:Aerosols; D010919:Placebos; D001507:Beclomethasone